Gregory Zante
Director of Finance/CFO at VIKING THERAPEUTICS, INC.
Net worth: 17 M $ as of 2024-03-30
Profile
Gregory S.
Zante is currently the Chief Financial Officer at Viking Therapeutics, Inc. He previously held positions as the Director-Finance & Administration at Calyx Therapeutics, Inc., the Senior Vice President at Matrix Pharmaceutical, Inc., the Senior Staff Accountant at Ernst & Young LLP, the Vice President-Finance & Administration at Sangamo Therapeutics, Inc., and the Chief Financial Officer at Aerami Therapeutics, Inc. Mr. Zante obtained his undergraduate degree from the University of California, Los Angeles.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
2024-03-26 | 207,361 ( 0.19% ) | 17 M $ | 2024-03-30 |
Gregory Zante active positions
Companies | Position | Start |
---|---|---|
VIKING THERAPEUTICS, INC. | Director of Finance/CFO | 2021-01-03 |
Former positions of Gregory Zante
Companies | Position | End |
---|---|---|
Aerami Therapeutics, Inc.
Aerami Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aerami Therapeutics, Inc. develops inhaled insulin products to treat diabetes patients. Its product Dance 501 is designed to produce consistently sized particles of liquid insulin in the form of a smooth mist, allowing the efficient and consistent delivery of insulin into the lungs in a few comfortable breaths. The company was founded by John Stuart Patton in February 9, 2009 and is headquartered in Durham, NC. | Director of Finance/CFO | 2015-12-31 |
SANGAMO THERAPEUTICS, INC. | Chief Administrative Officer | 2013-05-31 |
Matrix Pharmaceutical, Inc.
Matrix Pharmaceutical, Inc. Medical SpecialtiesHealth Technology Matrix Pharmaceutical, Inc. is a company that researches and develops pharmaceutical products. The company is based in Fremont, CA. The company was founded in 1985 by Dennis M. Brown. Matrix Pharmaceutical was acquired by Chiron Corp. on February 19, 2002 for $58.63 million. | Corporate Officer/Principal | 2001-11-30 |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Corporate Officer/Principal | 1995-10-31 |
Training of Gregory Zante
University of California, Los Angeles | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
SANGAMO THERAPEUTICS, INC. | Health Technology |
VIKING THERAPEUTICS, INC. | Health Technology |
Private companies | 3 |
---|---|
Matrix Pharmaceutical, Inc.
Matrix Pharmaceutical, Inc. Medical SpecialtiesHealth Technology Matrix Pharmaceutical, Inc. is a company that researches and develops pharmaceutical products. The company is based in Fremont, CA. The company was founded in 1985 by Dennis M. Brown. Matrix Pharmaceutical was acquired by Chiron Corp. on February 19, 2002 for $58.63 million. | Health Technology |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Commercial Services |
Aerami Therapeutics, Inc.
Aerami Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aerami Therapeutics, Inc. develops inhaled insulin products to treat diabetes patients. Its product Dance 501 is designed to produce consistently sized particles of liquid insulin in the form of a smooth mist, allowing the efficient and consistent delivery of insulin into the lungs in a few comfortable breaths. The company was founded by John Stuart Patton in February 9, 2009 and is headquartered in Durham, NC. | Health Technology |
- Stock Market
- Insiders
- Gregory Zante